öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºËïè¤Â¡
ÐÔ±ð£º
ÈËÆøÖ¸Êý£º120

ËùÊôԺУ£ºÎ÷±±¹¤Òµ´óѧ
ËùÊôԺϵ£ºÉúÃüѧԺ
Ö°³Æ£º¸±½ÌÊÚ
µ¼Ê¦ÀàÐÍ£º
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÏ¸°ûÉúÎïѧ¡¢ÉúÎﻯѧÓë·Ö×ÓÉúÎïѧ¡¢ÉúÎïѧ¡¢Ò©Ñ§


ͨѶ·½Ê½ :
°ì¹«µç»°£º**
µç×ÓÓʼþ£ºyulongsun@nwpu.edu.cn


¸öÈ˼òÊö :
1. ÈÙ»ñҽѧԺ1999¡«2000ѧÄêÒ»µÈ½±Ñ§½ð¼æÈýºÃÉú³ÆºÅ£» 2. ÈÙ»ñҽѧԺµÚÎå½ì´óѧÉú±çÂÛÈüÈýµÈ½±£» 3. ÈÙ»ñҽѧԺ2000Äê¶Èϵ¾«ÉñÎÄÃ÷´óѧÉú³ÆºÅ£» 4. ÈÙ»ñ2000Äê¶ÈÄê¶ÈÁª°îҽѧ½ÌÓý½±Ñ§½ð³ÆºÅ£» 5. ÈÙ»ñ2002ÄêҽѧԺµÚ¶þ½ì´óѧÉúÓ¢ÓïÑݽ²±ÈÈüµÚÈýÃû£» 6. ÈÙ»ñÎ÷±±¹¤Òµ´óѧ2014-2015ѧÄêÓÅÐã½Ìѧ³É¹û½±£¨6/7£©. 7. ÈÙ»ñÎ÷±±¹¤Òµ´óѧ2015 ÎâÑǾüÐÂÈ˽± 8. ÈÙ»ñÎ÷±±¹¤Òµ´óѧ2016¡°·ÛÎÒ×î°®µÄ¹¤´óÀÏʦ¡±£¨È«Ð£Ç°Î壩 9. ÈÙ»ñ2016Î÷±±¹¤Òµ´óѧÓÅÐãÇàÄê½Ìʦ£¨Ò»µÈ½±£©

¿ÆÑй¤×÷ :
2015/4 ¨C ÖÁ½ñ£¬Î÷±±¹¤Òµ´óѧ£¬ÉúÃüѧԺ£¬¸±½ÌÊÚ 2015/1 ¨C 2015/3£¬Î÷±±¹¤Òµ´óѧ£¬ÉúÃüѧԺ£¬½²Ê¦ 2012/12 ¨C 2014/12£¬Î÷±±¹¤Òµ´óѧ£¬ÉúÃüѧԺº½¿ÕÓ¿ÆѧÓë¼¼Êõ¿ÆÑÐÁ÷¶¯Õ¾£¬²©Ê¿ºó Ëïè¤Â¡£¬ÄУ¬¸±½ÌÊÚ£¬³öÉúÓÚ1982Äê2Ô¡£2004Äê±ÏÒµÓÚÀ¼ÖÝ´óѧÁÙ´²Ò½Ñ§öλÔÓéÀֵǼÈë¿ÚÏÂÔØ£¬2007ÄêºÍ2012ÄêÓÚÀ¼ÖÝ´óѧ·Ö»ñÉúÎﻯѧÓë·Ö×ÓÉúÎïѧ˶ʿ¡¢²©Ê¿Ñ§Î»£¬2012Äê12ÔÂÖÁ2014Äê12ÔÂÔÚÎ÷±±¹¤Òµ´óѧÉúÃüѧԺº½¿ÕÓ¿ÆѧÓë¼¼Êõ¿ÆÑÐÁ÷¶¯Õ¾´ÓÊÂÑо¿¹¤×÷£¬2015Äê1Ô½øÈëÎ÷±±¹¤Òµ´óѧÉúÃüѧԺ¹¤×÷£¬2015Äê4Ô½úÉýΪ¸±½ÌÊÚ¡£ Ö÷Òª´ÓʾÞÊÉϸ°û¹¦Äܵ÷¿ØÑо¿£¬Î§ÈƾÞÊÉ·Ö»¯ÕâÒ»»ù±¾Ï¸°û»î¶¯£¬´ÓÃâÒßѧ½Ç¶ÈÀí½â¾ÞÊÉϸ°ûÔÚÑ×Ö¢ÖеĻúÖÆ£¬ÒÔ¼°ÃâÒßµ÷½ÚëĶÔÆäÓ°Ï죬²¢Á¦Í¼ÌṩÐÂÐ͸ÉÔ¤·Ö×Ó¡£²ÎÓë¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÖØ´óÑо¿¼Æ»®¡¢ÃæÉÏÏîÄ¿µÈ4Ïî¡£Ö÷³Ö10Ïî¿ÆÑÐÏîÄ¿£¬ÆäÖйú¼Ò×ÔÈ»¿Æѧ»ù½ð2Ïî¡¢Öйú²©Ê¿ºó¿Æѧ»ù½ð2Ïî¡¢ÉÂÎ÷Ê¡×ÔÈ»¿Æѧ»ù½ð£¨ÇàÄêÈ˲ÅÏîÄ¿£©1Ïî¡¢ÉÂÎ÷Ê¡²©Ê¿ºó¿ÆÑÐ×ÊÖúÏîÄ¿1Ïî¡¢ÖÐÑë¸ßУ»ù±¾¿ÆÑÐÒµÎñ·Ñ×ÊÖú3Ïî¡£ÖÁ½ñ·¢±íѧÊõÂÛÎÄ17ƪ£¬ÒÔµÚÒ»×÷ÕßÔÚIEEE Transactions on Biomedical Engineering¡¢Advanced Synthesis & Catalysis¡¢PeptidesµÈѧÊõÆÚ¿¯·¢±íSCIÊÕ¼ÂÛÎÄ10ƪ£¬ÉêÇë²¢»ñÅú¹ú¼Ò·¢Ã÷רÀû1ÏΪ¹ú¼Ê»ªÈ˹ÇÑÐѧ»á¡¢ÉÂÎ÷ʡϸ°ûÉúÎïѧѧ»á¡¢Öйú¿Õ¼ä¿Æѧѧ»á¿Õ¼äÉúÃüöλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á»áÔ±¡¢¹ú¼Ò¿Æ¼¼×¨¼Ò¿âÔÚ¿âר¼Ò¡£»ñÎ÷±±¹¤Òµ´óѧ2016ÓÅÐãÇàÄê½Ìʦ¡¢Î÷±±¹¤Òµ´óѧ2016¡°·ÛÎÒ×î°®µÄ¹¤´óÀÏʦ¡±£¨ÈëÑ¡Ç°Î壩¡¢Î÷±±¹¤Òµ´óѧ2015ÎâÑǾüÐÂÈ˽±£¬Î÷±±¹¤Òµ´óѧ2014-2015ѧÄêÓÅÐã½Ìѧ³É¹û½±1Ï5/6£©¡£Peptides£¨SCIÆÚ¿¯£©¡¢BMC Veterinary Research£¨SCIÆÚ¿¯£©¡¢Protein & Peptide LettersÔÓÖ¾£¨SCIÆÚ¿¯£©Éó¸åÈË¡£ÃÀ¹ú¶àëÄЭ»á£¨American Peptide Society, APS£©»áÔ±¡¢Å·ÖÞ¶àëÄЭ»á£¨The European Peptide Society, EPS£©»áÔ±¡£? öλÔÓéÀֵǼÈë¿ÚÏÂÔØÌس¤£º·Ö×ÓÉúÎïѧ¡¢»ùÒò¹¤³Ì¡¢Ï¸°ûÉúÎïѧ¡£? ¿ÆÑÐÏîÄ¿ ¿ÆÑÐÏîÄ¿-Ö÷³ÖÕß ¿ÆÑÐÏîÄ¿-Ö÷³ÖÕß 1. ? Ëïè¤Â¡£¬¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð/Ó¦¼±¹ÜÀíÏîÄ¿£ºmiR-30e-3pµ÷¿ØNPFFR2²ÎÓëÄ£ÄâʧÖØÒÖÖƾÞÊÉϸ°ûÃâÒß¹¦ÄܵÄÑо¿£¨20Íò£¬×ÊÖú±àºÅ£º**£¬2018.1-2018.12£¬½øÐÐÖУ© 2. ? Ëïè¤Â¡£¬Öйú²©Ê¿ºó¿Æѧ»ù½ðÃæÉÏ×ÊÖú£ºmiR-30e-3pµ÷¿ØNPFFR2²ÎÓë¾ÞÊÉϸ°ûÒÖÖÆÑ×Ö¢µÄ»úÖÆÑо¿£¨¶þµÈ£¬5Íò£¬×ÊÖú±àºÅ£º2017M623250£¬2017.11-2019.11£¬½øÐÐÖУ© 3. ? Ëïè¤Â¡£¬¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð/ÇàÄê»ù½ð£ºÄ£ÄâʧÖØÌõ¼þÏÂÃâÒßµ÷½ÚëÄNPFF¶ÔÆƹÇϸ°û·Ö»¯µÄÓ°Ï죨23Íò£¬×ÊÖú±àºÅ£º**£¬2015.1-2017.12£¬ÒѽáÌâ?£© 4. ? Ëïè¤Â¡£¬ÉÂÎ÷Ê¡×ÔÈ»¿Æѧ»ù´¡Ñо¿¼Æ»®£¨ÇàÄêÈ˲ÅÏîÄ¿£©£ºÃâÒßµ÷½ÚëÄNPFF¶ÔÀà·çʪ¹Ø½ÚÑ×Ó°ÏìµÄʵÑéÑо¿£¨4Íò£¬×ÊÖú±àºÅ£º2016JQ8009£¬2016.1-2017.12£¬ÒѽáÌâ?£© 5. ? Ëïè¤Â¡£¬ÖÐÑë¸ßУ»ù±¾¿ÆÑÐÒµÎñ·Ñ¿ÆÑÐ×ÊÖúÏîÄ¿£ºNF kappa BÐźÅͨ·²ÎÓëNPFFµ÷½Ú¾ÞÊÉϸ°ûÃâÒß¹¦ÄܵĻúÖÆÑо¿£¨8Íò£¬×ÊÖú±àºÅ£º**OQD038£¬2017.1-2018.12£¬½øÐÐÖУ© 6. ? Ëïè¤Â¡£¬ÖÐÑë¸ßУ»ù±¾¿ÆÑÐÒµÎñ·Ñ¿ÆÑÐ×ÊÖúÏîÄ¿£ºÃâÒßµ÷½ÚëÄNPFF¶Ô¾ÞÊÉϸ°ûÃâÒßµ÷¿ØµÄʵÑéÑо¿£¨15Íò£¬×ÊÖú±àºÅ£º**ZY040£¬2016.1-2017.12£¬ÒѽáÌâ?£© 7. ? Ëïè¤Â¡£¬Öйú²©Ê¿ºó¿Æѧ»ù½ðÃæÉÏ×ÊÖú£ºÄ£ÄâʧÖØÌõ¼þÏÂÉñ¾­ëÄFF¶ÔÆƹÇϸ°û·Ö»¯³ÉÊìµÄÓ°Ï죨¶þµÈ£¬5Íò£¬×ÊÖú±àºÅ£º2014M552492£¬2014.1-2015.12£¬ÒѽáÌ⣩ 8. ? Ëïè¤Â¡£¬ÖÐÑë¸ßУ»ù±¾¿ÆÑÐÒµÎñ·Ñ¿ÆÑÐ×ÊÖúÏîÄ¿£ºÎ¢¹Ü΢˿½»Áª·Ö×ÓÌìÈ»·´ÒåRNAɸѡ¼°Æä¶ÔСÊó¹ÇÐγɵÄÓ°Ï죨15Íò£¬×ÊÖú±àºÅ£º**JKY15010£¬2014.6-2015.12£¬ÒѽáÌ⣩ 9. ? Ëïè¤Â¡£¬ÉÂÎ÷Ê¡²©Ê¿ºó¿ÆÑÐÏîÄ¿£ºÉñ¾­ëÄFF¶ÔÆƹÇϸ°û¹ÇÎüÊÕ¹¦Äܵĵ÷½ÚÑо¿£¨2Íò£¬2014.1-2015.12£¬ÒѽáÌ⣩ 10. Ëïè¤Â¡£¬Î÷±±¹¤Òµ´óѧ²©Ê¿ºó¿ÆÑлù½ð£ºÒÔÉñ¾­ëÄFFΪ´ú±íµÄ¶àëÄÀàDZÔÚÒ©Îï·Ö×ÓÔÚº½Ìì¹Ç¶ªÊ§¹ý³ÌÖеÄ×÷Óü°×÷ÓûúÖÆÑо¿£¨1.2Íò£¬2012.12-2014.12£¬ÒѽáÌ⣩ ¿ÆÑÐÏîÄ¿-²ÎÓëÕß 1. ? ¹ú¼Ò¡°973¡±¼Æ»®¿ÎÌ⣬¶¯Îïϸ°û¶Ô£¨Î¢£©ÖØÁ¦µÄ¸ÐÖª¡¢´«µ¼¡¢ÏàÓ¦¹æÂÉ. 2011CB710903£¬ÒѽáÌ⣬²Î¼Ó¡£ 2. ? ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÇàÄê¿Æѧ»ù½ðÏîÄ¿£¬MACF1ͨ¹ýWnt/¦Â-cateninÐźÅͨ·²ÎÓëÄ£ÄâʧÖØÒÖÖƳɹÇϸ°û·Ö»¯µÄ»úÖÆÑо¿£¬**£¬2015/01-2017/12£¬25Íò£¬ÔÚÑУ¬²Î¼Ó¡£ 3. ? ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿£¬Ë«¹¦Äܼ¤»î-´ß»¯µÄ²»¶Ô³Æ·´×ªµç×ÓµÄDiels-Alder·´Ó¦Ñо¿£º¹¹½¨ÊÖÐÔ´ó»··Ö×ÓµÄÐÂ;¾¶£¬**£¬2013/01-2016/12£¬80Íò£¬ÒѽáÌ⣬²Î¼Ó¡£ 4. ? ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿£¬°¢Æ¬/Éñ¾­ëÄFFÊÜÌåµÄË«¹¦ÄÜëÄÀàÅäÌåµÄ»¯Ñ§¹¹½¨¼°ÆäÎÞÄÍÊÜÕòÍ´ÌØÐÔµÄÑо¿£¬**£¬2013/01-2016/12£¬65Íò£¬ÒѽáÌ⣬²Î¼Ó¡£ 5. ? ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿£¬MACF1¼°ÆäÌìÈ»·´Òåת¼ÎïÔÚÄ£ÄâʧÖØÓ°Ïì³É¹ÇÇ°Ìåϸ°ûǨÒÆÖеÄ×÷Óã¬**£¬2015/01-2015/12£¬15Íò£¬ÒѽáÌ⣬²Î¼Ó¡£ 6. ? ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÖØ´óÑо¿¼Æ»®/ÅàÓýÏîÄ¿£¬»ùÓÚÉñ¾­ëĶø¹¹½¨µÄÁ½ÀàÐÂÐÍÅäÌåÔÚMu°¢Æ¬ÊÜÌå¾ÛºÏÌåµÄÐźÅתµ¼ºÍÍ´¾õµ÷½ÚÑо¿ÖеÄÓ¦Óã¬**£¬2009/01-2011/12£¬50Íò£¬ÒѽáÌ⣬²Î¼Ó¡£ 7. ? ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÇàÄê¿Æѧ»ù½ðÏîÄ¿£¬»·¾³Ãô¸ÐÐÔÓ«¹â°±»ùËáÔÚÐÂÐÍNPFF1ºÍNPFF2¸ßÑ¡ÔñÐÔÅäÌåµÄÉè¼ÆºÍºÏ³ÉÖеÄÓ¦Óã¬**£¬2010/01-2012/12£¬22Íò£¬ÒѽáÌ⣬²Î¼Ó¡£ ÂÛÎÄ ·¢±íÂÛÎÄ-µÚÒ»×÷Õß 1. Yu-Long Sun, Di-Jie Li, Ru Zhang, Shang Peng, Ge Zhang, Tuanming Yang *, Airong Qian *. Strategies to Identify Natural Antisense Transcripts. Biochimie. 2017, 132, 131-151 (IF 3.017, SCIÈýÇø). WOS:**015 2. Yu-Long Sun#, Jia Liu#(co-first author), Xian-Xing Jiang#*, Tao Sun, Lu-Ping Liu, Xiao-Yuan Zhang, Shao-Li Ding, Jing-Yi Li, Yan Zhuang, Yi-Qing Wang, Rui Wang*. One-Step Synthesis of Chiral Oxindole-type Analogues with Potent Antiinflammatory and Analgesic Activities. Scientific Reports. 2015, 5, 13699 (IF 4.259, SCI ÈýÇø). WOS:**002 3. Yu-Long Sun#, Jia Liu#(co-first author), Tao Sun, Xiao-Yuan Zhang, Jia Yao, Ming Kai, Xian-Xing Jiang*, Rui Wang*. Anti-cancer small molecule JP-8g exhibits potent in vivo anti-inflammatory activity. Scientific Reports. 2014, 4, 4372 (IF 4.259, SCIÈýÇø). WOS:**001 4. Yu-Long Sun, Zhi-Hao Chen, Xiao-Hu Chen, Chong Yin, Di-Jie Li, Xiao-Li Ma, Fan Zhao, Ge Zhang, Peng Shang, Ai-Rong Qian*. Diamagnetic levitation promotes osteoclast differentiation from RAW264.7 cells. IEEE Transactions on Biomedical Engineering. 2015, 62(3): 900-908 (IF 3.577, SCI¶þÇø). WOS:**011 5. Yu-Long Sun, Xiao-Hu Chen, Zhi-Hao Chen, Xiao-Li Ma, Di-Jie Li, Peng Shang, Ai-Rong Qian*. Neuropeptide FF attenuates RANKL-induced differentiation of RAW264.7 cells into osteoclast-like cells. Archives of Oral Biology. 2015, 60, 282-292 (IF 1.748, SCIÈýÇø). WOS:**008 6. Yu-Long Sun, Xiao-Yuan Zhang, Tao Sun, Ning He, Jing-Yi Li, Yan Zhuang, Qian Zeng, Jing Yu, Quan Fang, Rui Wang*. The anti-inflammatory potential of neuropeptide FF in vitro and in vivo. Peptides. 2013, 47, 124-132 (IF 2.778, SCIÈýÇø). WOS:**018 7. Yu-Long Sun, Xiao-Yuan Zhang, Ning He, Tao Sun, Yan Zhuang, Quan Fang*, Kai-Rong Wang, Rui Wang*. Neuropeptide FF activates ERK and NF kappa B signal pathways in differentiated SH-SY5Y cells. Peptides. 2012, 38, 110-117 (IF 2.778, SCIÈýÇø). WOS:**015 8. Yu-Long Sun, Tao Sun, Xiao-Yuan Zhang, Ning He, Yan Zhuang, Jing-Yi Li, Quan Fang, Kai-Rong Wang, Rui Wang*. NPFF2 receptor is involved in the modulatory effects of neuropeptide FF for macrophage cell line. Protein & Peptide Letters. 2014, 21, 490-502 (IF 1.069, SCIËÄÇø). WOS:**011 9. Yu-Long Sun, Zhi-Hao Chen, Xiao-Li Ma, Di-Jie Li, Fan Zhao, Peng Shang, Tuan-Ming Yang*, Ai-Rong Qian*. Neuropeptide FF inhibits LPS-mediated osteoclast differentiation of RAW264.7 cells. Protein & Peptide Letters. 2015, 22, 270-284 (IF 1.069, SCIËÄÇø). WOS:**010 10. ? Ëïè¤Â¡, ÂíСÀò, ÀîµÏ½Ü, ÕÔ·«, å¹°®ÈÙ*. Éñ¾­ëÄFFµÄÉúÎï»îÐÔÑо¿½øÕ¹. ÏÖ´úÉúÎïҽѧ½øÕ¹. 2015, 15, 1365-1368 (¿Æ¼¼ÂÛÎÄͳ¼ÆÔ´ÆÚ¿¯). 11. ? Xian-Xing Jiang#, Yu-Long Sun#(co-first author), Jia Yao#, Yi-Ming Cao, Ming Kai, Ning He, Xiao-Yuan Zhang, Yi-Qing Wang, Rui Wang*. Core scaffold-inspired concise synthesis of chiral spirooxindole-pyranopyrimidines with broad-spectrum anticancer potency. Advanced Synthesis & Catalysis. 2012, 354, 917-925 (IF 5.646, SCI¶þÇø). WOS:**022 12. ? Jia Liu#, Yu-Long Sun#(co-first author), Xue-Hong Zhang#, Xiao-Lei Liang, Yan-Jing Wu, Yi-Qing Wang*, Xian-Xing Jiang*. Spirooxindoles, a potential novel class of anti-inflammatory agents. Inflammation and Cell Signaling. 2014, 1:e372 (IF not available yet). 13. ? Ëïè¤Â¡, Áø¼ÍÊ¡*, κ»¢À´, ÀîѧÈð. ÖíÁ´Çò¾ú2 ÐÍmrp »ùÒòORF1 ÐòÁеĿË¡¼°Ô­ºË±í´ï. ÖйúÊÞÒ½¿Æѧ. 2007, 37, 675-678 (ÖÐÎĺËÐÄÆÚ¿¯). ·¢±íÂÛÎÄ-ÆäËü×÷Õß 1. Tao Sun, Chun-Xia Wang*, Dong-Hai Li, Yan-Yun Ma, Yin-Zhong Bu, Tuan-Jie Che, Yu-Long Sun. Neuropeptide FF Attenuates Inflammatory Response on Type II Collagen-Induced Arthritis in Mice. Latin American Journal of Pharmacy. 2017, 36, 68-74 (IF 0.329, SCIËÄÇø). 2. Li Ning, Zhen-Lan Han, Zi-Long Wang, Yan-Hong Xing, Yu-Long Sun, Xing-Hui Li, Jing-Jing Song, Ting Zhang, Run Zhang, Meng-Na Zhang, Biao Xu, Quan Fang*, Rui Wang*. BN-9, a chimeric peptide with mixed opioid and NPFF receptors agonistic properties, produces nontolerance-forming antinociception in mice. British Journal of Pharmacology. 2017, 173, 1864¨C1880 (IF 5.491,SCI¶þÇø). 3. ³ÂÏþ»¢, Ëïè¤Â¡, å¹°®ÈÙ, À±¦*, ÉÌÅì. ÆƹÇϸ°ûµÄÐγɺͻÑо¿½øÕ¹. Öйúϸ°ûÉúÎïѧѧ±¨. 2014, 36(2), 258-266 (CSCD). 4. Yasir Arfat, Wei-Zhong Xiao, Salman Iftikhar, Fan Zhao, Di-Jie Li, Yu-Long Sun, Ge Zhang, Peng Shang, Ai-Rong Qian*. Physiological effects of microgravity on bone cells. Calcified Tissue International and Musculoskeletal Research. 2014, 94, 569-579 (IF 3.272, SCIÈýÇø). 5. Yasir Arfat, Wei-Zhong Xiao, Munazza Ahmad, Fan Zhao, Di-Jie Li, Yu-Long Sun, Li-Fang Hu, Zhi-Hao Chen, Ge Zhang, Peng Shang, Ai-Rong Qian*. Role of microRNAs in osteoblasts differentiation and bone disorders. Current Medicinal Chemistry. 2015, 22, 748-758 (IF 3.853, SCI¶þÇø). 6. Fan Zhao, Di-Jie Li, Zhi-Hao Chen, Zong-Lin Liu, Yu Lin, Chong Ding, Yu-Long Sun, Li-Fang Hu, Peng Shang, Ai-Rong Qian*. Reloading partly recovers bone mineral density and mechanical properties in hind limb unloaded rats. Acta Astronautica. 2014, 105, 57-65 (IF 1.122, SCIËÄÇø). 7. º«ÏþÈÙ, Áø¼ÍÊ¡*, Ñî±ò, Ëïè¤Â¡, Àǿ, À¼Ï², ÒóÏàƽ, ÀÓñ, ÀîѧÈð, ºúÓÀºÆ. ÑÇÖÞ1ÐÍ¿ÚÌãÒß²¡¶¾·´ÒåºËËáË«Ïò±í´ïÔØÌåµÄ¹¹½¨. ¶¯Îïҽѧ½øÕ¹£® 2008, 29, 1¨C5 (ÖÐÎĺËÐÄÆÚ¿¯). »áÒéÂÛÎÄ 1. ? Ëïè¤Â¡, ÂíСÀò, ÉÌÅì, å¹°®ÈÙ*. Éñ¾­ëÄFFÒÖÖÆRANKLÓÕµ¼ÆƹÇϸ°ûµÄ·Ö»¯Ñо¿, ÉÂÎ÷ʡϸ°ûÉúÎïѧѧ»á2014ÄêÄê»á, 2014.11.7-9, ÏÌÑô, Öйú. 2. ? Ëïè¤Â¡, ³ÂÖ¾ºÆ, ³ÂÏþ»¢, ÂíСÀò, ÀîµÏ½Ü, ÉÌÅì, å¹°®ÈÙ*.¿¹´ÅÐü¸¡´Ù½øRANKLÓÕµ¼ÆƹÇϸ°ûµÄ·Ö»¯, Öйú¿Õ¼ä¿Æѧѧ»á¿Õ¼äÉúÃüöλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»áµÚ¶þÊ®½ìѧÊõÑÐÌÖ»á, 2014.11.5-7, ÄÏÄþ, Öйú. 3. ? Yu-Long Sun, Xiao-Hu Chen, Zhi-Hao Chen, Xiao-Li Ma, Di-Jie Li, Fan Zhao, Peng Shang, Ai-Rong Qian*. Neuropeptide FF attenuates RANKL-induced osteoclast formation in RAW264.7 cells, 2014 International Symposium for Space Biology and Biomedical Engineering, April 12-14, 2014, Xi¡¯an, China. 4. ? ·½Èª, Ëïè¤Â¡, ÀîÄþ, º«Õþá°, ÍõÈñ*. Éñ¾­ëÄFFϵͳÞ׿¹¼ÁRF9µÄÈ«ÐÂÀàËÆÎ¡ª2-½ð¸ÕÍéõ£-RFaµÄ¹¦ÄÜÐÔ¼ø¶¨, ÖйúÉúÀíѧ»áµÚ¾Å½ìÈ«¹úÇàÄêÉúÀíѧ¹¤×÷ÕßѧÊõ»áÒéÂÛÎÄÕªÒª, 20-21Ò³, 2011.10.21-23, ±±¾©, Öйú. »áÒéǽ±¨ 1. ? Yu-Long Sun, Zhi-Hao Chen, Xiao-Hu Chen, Xiao-Li Ma, Di-Jie Li, Peng Shang*, Ai-Rong Qian*. Diamagnetic Levitation Promotes Osteoclast Differentiation from RAW264.7 Cells. Öйú¿Õ¼ä¿Æѧѧ»á¿Õ¼äÉúÃüöλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»áµÚ¶þÊ®½ìѧÊõÑÐÌÖ»á, 2014.11.5-8, ÄÏÄþ, Öйú. 2. ? Yu-Long Sun,Xiao-Hu Chen, Ai-Rong Qian*. Neuropeptide FF Attenuates RANKL-induced Osteoclast Formation in RAW264.7 Cells. 2014 International Symposium for Space Biology and Biomedical Engineering, 2014.4.12-14, Î÷°², Öйú. 3. ? Yu-Long Sun,Quan Fang, Ning Li, Zheng-Lan Han, Rui Wang*. Pharmacological characterisation of 2-adamantanecarbonyl-RF-amide, a novel analog of NPFF receptors antagonist RF9. 11th International Chinese Peptide Symposium, 2010.7.5-8, À¼ÖÝ, Öйú. רÀû 1. ? ÍõÈñ£¬½¯ÏÈÐË£¬Ëïè¤Â¡¡£ÊÖÐÔÂÝ»·ßÅßá-ßÁà«à×़îÀ໯ºÏÎïÔÚÖƱ¸¿¹Ñ×Ò©ÎïÖеÄÓ¦Óã¬CN**A£¨¹«¿ªºÅ£©£¬**£¨×¨ÀûºÅ£©, ¹«¿ªÈÕÆÚ£º2014.3.12. Öйú£¨¹ú¼Ò·¢Ã÷רÀû£©.

½ÌÓý±³¾° :
2007/09 ¨C 2012/12£¬À¼ÖÝ´óѧ£¬ÉúÃü¿ÆѧѧԺ£¬ÉúÎﻯѧÓë·Ö×ÓÉúÎïѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£¬²©Ê¿£¨µ¼Ê¦£ºÍõÈñ ½ÌÊÚ Öйú¹¤³ÌԺԺʿ£©£¨·½Ïò£º¶àëÄÒ©ÎïÑз¢£© 2004/09 ¨C 2007/06£¬À¼ÖÝ´óѧ£¬Ò½Ñ§Ôº£¬ÉúÎﻯѧÓë·Ö×ÓÉúÎïѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£¬Ë¶Ê¿£¨µ¼Ê¦£ºÎº»¢À´ ½ÌÊÚ£©£¨·½Ïò£º»ùÒò¹¤³Ì£© 1999/09 ¨C 2004/06£¬À¼ÖÝ´óѧ£¬Ò½Ñ§Ôº£¬ÁÙ´²Ò½Ñ§Ôº£¬Ñ§Ê¿ £¨·½Ïò£ºÁÙ´²Ò½Ñ§£©